National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Akynzeo® is indicated for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy and for prevention of acute and delayed nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

 

Rapid Review

Commenced Completed Outcome
26/08/2015 13/10/2015 Full Pharmacoeconomic Evaluation Not Recommended